Global Conjugate Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 145956
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 131
  • list Medical Devices

Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.

Scope of the Report:

This report focuses on the Conjugate Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis.

The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.

The worldwide market for Conjugate Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Novartis

Neuron Biotech

Serum Institute of India

Pfizer

Sanofi Pasteur

Bharat Biotech

Biological

GlaxoSmithKline

Merck

CSL

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monovalent Conjugate Vaccines

Multivalent Conjugate Vaccines

Market Segment by Applications, can be divided into

Pediatrics

Adults

There are 15 Chapters to deeply display the global Conjugate Vaccines market.

Chapter 1, to describe Conjugate Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Conjugate Vaccines, with sales, revenue, and price of Conjugate Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Conjugate Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Conjugate Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Conjugate Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Conjugate Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 Monovalent Conjugate Vaccines

1.2.2 Multivalent Conjugate Vaccines

1.3 Market Analysis by Applications

1.3.1 Pediatrics

1.3.2 Adults

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Business Overview

2.1.2 Conjugate Vaccines Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Neuron Biotech

2.2.1 Business Overview

2.2.2 Conjugate Vaccines Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Neuron Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Serum Institute of India

2.3.1 Business Overview

2.3.2 Conjugate Vaccines Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Serum Institute of India Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Pfizer

2.4.1 Business Overview

2.4.2 Conjugate Vaccines Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Pfizer Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Sanofi Pasteur

2.5.1 Business Overview

2.5.2 Conjugate Vaccines Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sanofi Pasteur Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bharat Biotech

2.6.1 Business Overview

2.6.2 Conjugate Vaccines Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bharat Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Biological

2.7.1 Business Overview

2.7.2 Conjugate Vaccines Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Biological Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 GlaxoSmithKline

2.8.1 Business Overview

2.8.2 Conjugate Vaccines Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 GlaxoSmithKline Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Merck

2.9.1 Business Overview

2.9.2 Conjugate Vaccines Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Merck Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 CSL

2.10.1 Business Overview

2.10.2 Conjugate Vaccines Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 CSL Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Conjugate Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Conjugate Vaccines Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Conjugate Vaccines Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Conjugate Vaccines Manufacturer Market Share in 2017

3.3.2 Top 6 Conjugate Vaccines Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Conjugate Vaccines Market Analysis by Regions

4.1 Global Conjugate Vaccines Sales, Revenue and Market Share by Regions

4.1.1 Global Conjugate Vaccines Sales and Market Share by Regions (2013-2018)

4.1.2 Global Conjugate Vaccines Revenue and Market Share by Regions (2013-2018)

4.2 North America Conjugate Vaccines Sales and Growth Rate (2013-2018)

4.3 Europe Conjugate Vaccines Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Conjugate Vaccines Sales and Growth Rate (2013-2018)

4.5 South America Conjugate Vaccines Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Conjugate Vaccines Sales and Growth Rate (2013-2018)

5 North America Conjugate Vaccines by Countries

5.1 North America Conjugate Vaccines Sales, Revenue and Market Share by Countries

5.1.1 North America Conjugate Vaccines Sales and Market Share by Countries (2013-2018)

5.1.2 North America Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)

5.2 United States Conjugate Vaccines Sales and Growth Rate (2013-2018)

5.3 Canada Conjugate Vaccines Sales and Growth Rate (2013-2018)

5.4 Mexico Conjugate Vaccines Sales and Growth Rate (2013-2018)

6 Europe Conjugate Vaccines by Countries

6.1 Europe Conjugate Vaccines Sales, Revenue and Market Share by Countries

6.1.1 Europe Conjugate Vaccines Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)

6.2 Germany Conjugate Vaccines Sales and Growth Rate (2013-2018)

6.3 UK Conjugate Vaccines Sales and Growth Rate (2013-2018)

6.4 France Conjugate Vaccines Sales and Growth Rate (2013-2018)

6.5 Russia Conjugate Vaccines Sales and Growth Rate (2013-2018)

6.6 Italy Conjugate Vaccines Sales and Growth Rate (2013-2018)

7 Asia-Pacific Conjugate Vaccines by Countries

7.1 Asia-Pacific Conjugate Vaccines Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Conjugate Vaccines Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)

7.2 China Conjugate Vaccines Sales and Growth Rate (2013-2018)

7.3 Japan Conjugate Vaccines Sales and Growth Rate (2013-2018)

7.4 Korea Conjugate Vaccines Sales and Growth Rate (2013-2018)

7.5 India Conjugate Vaccines Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Conjugate Vaccines Sales and Growth Rate (2013-2018)

8 South America Conjugate Vaccines by Countries

8.1 South America Conjugate Vaccines Sales, Revenue and Market Share by Countries

8.1.1 South America Conjugate Vaccines Sales and Market Share by Countries (2013-2018)

8.1.2 South America Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Conjugate Vaccines Sales and Growth Rate (2013-2018)

8.3 Argentina Conjugate Vaccines Sales and Growth Rate (2013-2018)

8.4 Colombia Conjugate Vaccines Sales and Growth Rate (2013-2018)

9 Middle East and Africa Conjugate Vaccines by Countries

9.1 Middle East and Africa Conjugate Vaccines Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Conjugate Vaccines Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Conjugate Vaccines Sales and Growth Rate (2013-2018)

9.3 UAE Conjugate Vaccines Sales and Growth Rate (2013-2018)

9.4 Egypt Conjugate Vaccines Sales and Growth Rate (2013-2018)

9.5 Nigeria Conjugate Vaccines Sales and Growth Rate (2013-2018)

9.6 South Africa Conjugate Vaccines Sales and Growth Rate (2013-2018)

10 Global Conjugate Vaccines Market Segment by Type

10.1 Global Conjugate Vaccines Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Conjugate Vaccines Sales and Market Share by Type (2013-2018)

10.1.2 Global Conjugate Vaccines Revenue and Market Share by Type (2013-2018)

10.2 Monovalent Conjugate Vaccines Sales Growth and Price

10.2.1 Global Monovalent Conjugate Vaccines Sales Growth (2013-2018)

10.2.2 Global Monovalent Conjugate Vaccines Price (2013-2018)

10.3 Multivalent Conjugate Vaccines Sales Growth and Price

10.3.1 Global Multivalent Conjugate Vaccines Sales Growth (2013-2018)

10.3.2 Global Multivalent Conjugate Vaccines Price (2013-2018)

11 Global Conjugate Vaccines Market Segment by Application

11.1 Global Conjugate Vaccines Sales Market Share by Application (2013-2018)

11.2 Pediatrics Sales Growth (2013-2018)

11.3 Adults Sales Growth (2013-2018)

12 Conjugate Vaccines Market Forecast (2018-2023)

12.1 Global Conjugate Vaccines Sales, Revenue and Growth Rate (2018-2023)

12.2 Conjugate Vaccines Market Forecast by Regions (2018-2023)

12.2.1 North America Conjugate Vaccines Market Forecast (2018-2023)

12.2.2 Europe Conjugate Vaccines Market Forecast (2018-2023)

12.2.3 Asia-Pacific Conjugate Vaccines Market Forecast (2018-2023)

12.2.4 South America Conjugate Vaccines Market Forecast (2018-2023)

12.2.5 Middle East and Africa Conjugate Vaccines Market Forecast (2018-2023)

12.3 Conjugate Vaccines Market Forecast by Type (2018-2023)

12.3.1 Global Conjugate Vaccines Sales Forecast by Type (2018-2023)

12.3.2 Global Conjugate Vaccines Market Share Forecast by Type (2018-2023)

12.4 Conjugate Vaccines Market Forecast by Application (2018-2023)

12.4.1 Global Conjugate Vaccines Sales Forecast by Application (2018-2023)

12.4.2 Global Conjugate Vaccines Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Conjugate Vaccines Picture

Table Product Specifications of Conjugate Vaccines

Figure Global Sales Market Share of Conjugate Vaccines by Types in 2017

Ta

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery